CareLit Fachartikel

Effects on cerebrospinal fluid biomarkers in multiple sclerosis patients after repeated intrathecal triamcinolone acetonid application

M Abu-Mugheisib, H Tumani, F Kamin, A Apel, W Köhler, F Hoffmann, R Benecke, UK Zettl · Aktuelle Neurologie · 2007 · Heft 09

Dokument
1076211
CareLit-ID
Jahr
2007
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Neurologie
Autor:innen
M Abu-Mugheisib, H Tumani, F Kamin, A Apel, W Köhler, F Hoffmann, R Benecke, UK Zettl
Ausgabe
Heft 09 / 2007
Seiten
–
Erschienen: 2007-09-11 00:00:00
ISSN
0302-4350
DOI
10.1055/s-2007-988026

Zusammenfassung

Objective: This pilot study wanted to characterize the effects on cerebrospinal fluid (CSF) Tau protein, S-100, interleukin (IL) -6-type cytokine, beta-trace protein (beta-trace) and beta-2 microglobulin (beta 2MG) induced by repeated intrathecal triamcinolone acetonid (TCA) applications in multiple sclerosis patients. Methods: In this prospective pilot study 10 patients suffering from Multiple Sclerosis(MS) (4 relapsing remitting [RR], 6 secondary or primary progressive [SP/PP]) were included. Three TCA applications were performed as part of an ongoing trial every second day to reduce spasticity. Results: The m…

Schlagworte

Observation Beta-2-Microglobulin beta 2-Microglobulin Cytokine Biomarkers After Aktuelle Neurologie